title: [An example of interactions between SSRI preparations and tolterodine?].
authors.forename: C
authors.initials: C
authors.lastname: von Segebaden
mesh_terms: D000928:Antidepressive Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000378:metabolism; D001559:Benzhydryl Compounds / Q000008:administration & dosage / Q000009:adverse effects* / Q000378:metabolism; D003408:Cresols / Q000008:administration & dosage / Q000009:adverse effects* / Q000378:metabolism; D004347:Drug Interactions; D006801:Humans; D018727:Muscarinic Antagonists / Q000008:administration & dosage / Q000009:adverse effects* / Q000378:metabolism; D010665:Phenylpropanolamine; D017367:Selective Serotonin Reuptake Inhibitors / Q000008:administration & dosage / Q000009:adverse effects* / Q000378:metabolism; D020280:Sertraline / Q000008:administration & dosage / Q000009:adverse effects* / Q000378:metabolism; D000068737:Tolterodine Tartrate
chemical_list: D000928:Antidepressive Agents; D001559:Benzhydryl Compounds; D003408:Cresols; D018727:Muscarinic Antagonists; D010665:Phenylpropanolamine; D017367:Selective Serotonin Reuptake Inhibitors; D020280:Sertraline; D000068737:Tolterodine Tartrate